Literature DB >> 7754860

Staging, scoring and grading of medulloblastoma. A postoperative prognosis predicting system based on the cases of a single institute.

U Sure1, W J Berghorn, H Bertalanffy, T Wakabayashi, J Yoshida, K Sugita, W Seeger.   

Abstract

Although recently survival of some medulloblastoma patients increased remarkably, it remains a serious diagnosis in others. In order to predict the postoperative prognosis in patients treated for medulloblastoma, a new staging, scoring and grading system was developed. Sixty-six patients operated on microsurgically between 1975 and 1990 at a single neurosurgical center were fully followed-up. No patient was excluded due to a poor postoperative course. Completion of commonly used radiotherapy protocols was attempted in all patients. Survival of patients was evaluated by the Kaplan-Meier method. The following 5 parameters were selected to define subgroups: patients' age, tumour location and histology, degree of resection and presence or absence of metastases. Patients older than 10 years had a better prognosis than individuals aged 10 or less (p < 0.01), patients with lateral tumours had a better prognosis than patients with midline tumours with brain stem infiltration (p < 0.05), patients with complete tumour resection had a more favourable prognosis than individuals with subtotal (p < 0.01) or partial resection (p < 0.001), patients without metastases at the time of diagnosis had a better prognosis than individuals without such evidence (p < 0.001), patients with the desmoplastic tumour variant had a better prognosis than patients with classical tumour histology (p < 0.01). According to the prognosis of a distinct subgroup, scoring points were distributed which correlated with the degree of inter-subgroup significances. The sum of a single patient's scoring points was called the total score. Based on this score, three groups of prognosis were distinguished.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7754860     DOI: 10.1007/BF01404849

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  32 in total

Review 1.  [Medulloblastoma: towards new prognostic factors].

Authors:  F San-Galli; J P Maire; J Guérin
Journal:  Neurochirurgie       Date:  1991       Impact factor: 1.553

2.  The risks of metastases from shunting in children with primary central nervous system tumors.

Authors:  M S Berger; B Baumeister; J R Geyer; J Milstein; P M Kanev; P D LeRoux
Journal:  J Neurosurg       Date:  1991-06       Impact factor: 5.115

3.  Prognostic importance of DNA ploidy in medulloblastoma of childhood.

Authors:  M Yasue; T Tomita; H Engelhard; F Gonzalez-Crussi; D G McLone; K D Bauer
Journal:  J Neurosurg       Date:  1989-03       Impact factor: 5.115

4.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.

Authors:  A E Evans; R D Jenkin; R Sposto; J A Ortega; C B Wilson; W Wara; I J Ertel; S Kramer; C H Chang; S L Leikin
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

5.  Medulloblastomas in childhood: histological factors influencing patients' outcome.

Authors:  K Taomoto; T Tomita; A J Raimondi; J E Leestma
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

6.  Medulloblastoma. A report of 201 cases with emphasis on the relationship of histologic variants to survival.

Authors:  E M Chatty; K M Earle
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

7.  Medulloblastomas in children.

Authors:  M Choux
Journal:  Childs Brain       Date:  1982

Review 8.  [The prognosis of medulloblastoma in adults].

Authors:  P Cornu; G Chatellier; F Fauchon; J F Foncin; T Faillot; D Dorwling-Carter; J Philippon
Journal:  Neurochirurgie       Date:  1990       Impact factor: 1.553

9.  Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management.

Authors:  G Kopelson; R M Linggood; G M Kleinman
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

10.  Infants with medulloblastoma: a single institution review of survival.

Authors:  R Geyer; M Levy; M S Berger; J Milstein; B Griffin; W A Bleyer
Journal:  Neurosurgery       Date:  1991-11       Impact factor: 4.654

View more
  12 in total

1.  Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients.

Authors:  U Sure; H Bertalanffy; S Isenmann; S Brandner; W J Berghorn; W Seeger; A Aguzzi
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 2.  A review of clinical and histological features of Spanish paediatric medulloblastomas during the last 21 years.

Authors:  Alejandro Urberuaga; Aurora Navajas; Juan Burgos; José Ignacio Pijoán
Journal:  Childs Nerv Syst       Date:  2005-11-09       Impact factor: 1.475

Review 3.  Recent advances in embryonal tumours of the central nervous system.

Authors:  Chitra Sarkar; Prabal Deb; Mehar Chand Sharma
Journal:  Childs Nerv Syst       Date:  2005-01-29       Impact factor: 1.475

Review 4.  Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.

Authors:  Jason T Huse; Eric C Holland
Journal:  Nat Rev Cancer       Date:  2010-05       Impact factor: 60.716

Review 5.  Medulloblastoma.

Authors:  Nathan E Millard; Kevin C De Braganca
Journal:  J Child Neurol       Date:  2015-09-02       Impact factor: 1.987

Review 6.  Medulloblastoma: recurrence and metastasis.

Authors:  Donya Aref; Sidney Croul
Journal:  CNS Oncol       Date:  2013-07

7.  Deregulated expression of PAX5 in medulloblastoma.

Authors:  Z Kozmik; U Sure; D Rüedi; M Busslinger; A Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

8.  Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.

Authors:  Stefan Rieken; Timo Gaiser; Angela Mohr; Thomas Welzel; Olaf Witt; Andreas E Kulozik; Wolfgang Wick; Jürgen Debus; Stephanie E Combs
Journal:  BMC Cancer       Date:  2010-08-23       Impact factor: 4.430

9.  The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system.

Authors:  A S Y W Burns; E Jaros; M Cole; R Perry; A J Pearson; J Lunec
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

10.  An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).

Authors:  H A Rogers; S Miller; J Lowe; M-A Brundler; B Coyle; R G Grundy
Journal:  Br J Cancer       Date:  2009-03-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.